Medipost Inc. to merge a bio tech company, Curonix

Published: 2005-08-26 06:56:00

Updated: 2005-08-26 06:56:00

Medipost Inc. announced on Aug. 23 that the company merged Curonix, a company specialized in the development and distribution of cancer drugs, cancer diagnostic reagents and other bio new drugs.

Medipost is specialized in the business related with the umbilical code bloods and recently designa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK